Pages that link to "Q41628899"
Jump to navigation
Jump to search
The following pages link to Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. (Q41628899):
Displaying 50 items.
- IRIZIO : a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS) (Q24319144) (← links)
- DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis (Q24683786) (← links)
- Mechanisms of impaired differentiation in rhabdomyosarcoma (Q26852728) (← links)
- p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress (Q27331653) (← links)
- Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene (Q28118453) (← links)
- Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls (Q30418118) (← links)
- Integrins regulate the apoptotic response to DNA damage through modulation of p53 (Q30453380) (← links)
- DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies (Q33886863) (← links)
- MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines (Q33915624) (← links)
- Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis. (Q34069279) (← links)
- Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma (Q34207682) (← links)
- Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers (Q34235576) (← links)
- DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells (Q34746238) (← links)
- Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway (Q35024843) (← links)
- Tumors associated with p53 germline mutations: a synopsis of 91 families. (Q35765327) (← links)
- The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. (Q35782290) (← links)
- Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma (Q35897781) (← links)
- Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma (Q35936863) (← links)
- Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma (Q36025454) (← links)
- Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells (Q36115862) (← links)
- DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy (Q36300839) (← links)
- Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis (Q36588372) (← links)
- Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours (Q36618015) (← links)
- Mutational status of K-ras and TP53 genes in primary sarcomas of the heart (Q36621284) (← links)
- Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines (Q36641915) (← links)
- Genetics of Bladder Malignant Tumors in Childhood (Q36658484) (← links)
- Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines (Q36674393) (← links)
- Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. (Q36689270) (← links)
- Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo (Q36930279) (← links)
- Orbital rhabdomyosarcomas: A review (Q37163456) (← links)
- Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells (Q37412018) (← links)
- Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. (Q37464647) (← links)
- Advances in pediatric rhabdomyosarcoma characterization and disease model development (Q37580831) (← links)
- Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. (Q37598848) (← links)
- Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events (Q37648694) (← links)
- Developmental origins of fusion-negative rhabdomyosarcomas. (Q37881290) (← links)
- Caveolins in rhabdomyosarcoma (Q37894860) (← links)
- Rhabdomyosarcomas: an overview on the experimental animal models. (Q37973827) (← links)
- Classification of rhabdomyosarcoma and its molecular basis. (Q38151409) (← links)
- Effects of RAS on the genesis of embryonal rhabdomyosarcoma. (Q38301662) (← links)
- New advances in the molecular biology of musculoskeletal neoplasms (Q38329613) (← links)
- Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma (Q38893243) (← links)
- SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth (Q38945547) (← links)
- Targeted polytherapy in small cell sarcoma and its association with doxorubicin (Q38977714) (← links)
- An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies (Q39531446) (← links)
- Zebrafish Models of Rhabdomyosarcoma (Q39561847) (← links)
- Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling (Q39811992) (← links)
- Targeting the p53 Pathway in Ewing Sarcoma. (Q41303735) (← links)
- Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53 /- mice (Q41380333) (← links)
- Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. (Q41849189) (← links)